Citizens Financial Group Inc Albemarle Corp Transaction History

Citizens Financial Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$162.63 - $243.44 $73,183 - $109,548	-450 Reduced 3.39%	12,833 $2.18 Million
Q2 2023 Aug 04, 2023	SELL	$172.91 - $232.22 $465,646 - $625,368	-2,693 Reduced 16.86%	13,283 $2.96 Million
Q1 2023 May 10, 2023	BUY	$208.49 - $290.15 $3.33 Million - $4.64 Million	15,976 New	15,976 $3.53 Million
Q1 2020 May 08, 2020	SELL	$50.9 - $94.31 $1,934 - $3,583	-38 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$60.74 - $73.04 $2,308 - $2,775	38 New	38 $3,000
Q3 2019 Nov 01, 2019	SELL	$59.3 - $75.53 $1,838 - $2,341	-31 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$63.3 - $86.94 $1,962 - $2,695	31 New	31 $2,000
Q3 2017 Nov 13, 2017	SELL	$109.36 - $136.31 $2,296 - $2,862	-21 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	21	21 $2,000

928

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.6B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.